Czech Pharma Producer Prices Down

10 February 1997

The Czech Statistical Office says producer prices of drug companies inthe Czech Republic fell 0.5% in 1996 compared to 1995, against a 4.8% rise in producer prices for Czech industry as a whole, reports CTK Business News.

CTK also reports that:

- the Czech Komercni Bank and the ITI Bank of Mongolia have signed an agreement for the provision of export credit lines, which should substantially increase Czech exports to Mongolia. Bilateral trade was worth only $6.8 million in the first nine months of 1996, but drugs are one of the main Czech exports to Mongolia.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight